Free Trial
NASDAQ:FONR

Fonar Q4 2025 Earnings Report

Fonar logo
$16.30 +1.24 (+8.23%)
Closing price 04:00 PM Eastern
Extended Trading
$16.38 +0.07 (+0.46%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Fonar EPS Results

Actual EPS
$0.11
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Fonar Revenue Results

Actual Revenue
$27.28 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Fonar Announcement Details

Quarter
Q4 2025
Time
After Market Closes
Conference Call Date
Monday, September 22, 2025
Conference Call Time
4:00PM ET

Earnings Documents

Fonar Earnings Headlines

Fonar (NASDAQ:FONR) Cut to Buy at Wall Street Zen
Fonar Corporation Delays Annual Report Filing
RIP USA
"The America you knew is dying in front of you" That's the urgent warning the former $200 million hedge fund firm manager who predicted 2008 and 2020 just issued. He says if you're over 50, there's one urgent move you need to make to survive... or risk getting left behind.tc pixel
Fonar Shares Rise on Buyout Offer
See More Fonar Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Fonar? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Fonar and other key companies, straight to your email.

About Fonar

Fonar (NASDAQ:FONR) is a medical technology company primarily engaged in the design, manufacture and sale of magnetic resonance imaging (MRI) systems. The company’s flagship product, the UPRIGHT® Multi-Position™ MRI, enables patients to be scanned in standing, seated and traditional recumbent positions, offering enhanced diagnostic capabilities for musculoskeletal, neurological and vascular conditions. In addition to MRI equipment sales, Fonar provides equipment installation, training and maintenance services to hospitals, imaging centers and private practices.

Headquartered in Melville, New York, Fonar markets its MRI systems both domestically and internationally, supported by a network of service engineers and customer support personnel. The company holds numerous patents covering MRI technology innovations, including its patented hydrostatic piston design that facilitates open‐gantry scanning. Fonar’s research and development efforts focus on expanding the clinical applications of multi-positional MRI, with an emphasis on improving patient comfort and diagnostic accuracy.

Through its subsidiaries, Fonar operates a chain of diagnostic imaging centers offering outpatient MRI services in key U.S. markets. These centers serve a broad spectrum of patients—from orthopedic and sports medicine referrals to neurology and spine care—leveraging Fonar’s unique imaging capabilities to inform treatment plans. The diagnostic services business complements the company’s equipment sales by providing ongoing revenue from scan fees, facility operations and patient referrals.

Founded in 1978 by Dr. Raymond V. Damadian—widely recognized as the inventor of the first MRI scanner—Fonar has maintained a pioneering role in medical imaging for over four decades. The company’s executive leadership continues to advance its core mission of developing innovative MRI solutions, expanding clinical applications and supporting healthcare providers worldwide in the early detection and management of disease.

View Fonar Profile

More Earnings Resources from MarketBeat